AIDS Treatment News
Table of Contents, May 31, 2002

• Treatment Access Emergency: ADAP and Medicaid
  Access to HIV and other medical care in the United States is becoming an increasingly serious problem. Both the ADAP and Medicaid programs urgently need activist attention.

• AIDSWatch Congressional Lobbying, June 9-11 in Washington
  Each year hundreds of people meet in Washington D.C. for workshops and visits with their Congressional representatives. Information is available on the Web, from the National Association of People with AIDS.

• Counterfeit Drugs: Check Combivir, Serostim, Epogen
  In May alone there have been at least three reports of mislabeled or counterfeit drugs that could have serious consequences for patients.
  Advertisement

• Medicaid Funding Cuts Affect People With AIDS Across the U.S.
  How state and federal budget problems are often making it difficult or impossible for patients to get proper care from Medicaid, which is by far the largest provider of AIDS care in the U.S.

• Johns Hopkins HIV Treatment Short Guide
  The 2002 Abbreviated Guide to Medical Management of HIV Infection is a bedside reference to HIV treatment for medical professionals. Well-informed patients can use it for background and understanding of their own care.

• Remune Controversy Articles
  Some leading HIV scientists want research to continue on the HIV immunogen developed many years ago by Dr. Jonas Salk -- not because they believe it is an effective product, but because important scientific issues could be addressed quickly. Until recently this view was scarcely heard in the public debate.

• Philadelphia: AIDS Education Month Talks and Programs
  Philadelphia FIGHT's AIDS Education Month includes more than 10 programs on immune-based therapy, clinical trials, recommended information sources, alternative therapies, the need for an HIV specialty, what is happening in prevention, responding to the global epidemic, and other topics.

ISSN # 1052-4207

Copyright 2002 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.